Cpwm, LLC Abb Vie Inc. Transaction History

Cpwm, LLC

$1.06 Billion
Q3 2022

A detailed history of Cpwm, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cpwm, LLC holds 31,283 shares of ABBV stock, worth $5.49 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

31,283

Previous 36,814 15.02%

Holding current value

$5.49 Million

Previous $5.64 Million 25.52%

% of portfolio

0.4%

Previous 0.5%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $742,315 - $851,386	-5,531 Reduced 15.02%	31,283 $4.2 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $422,631 - $537,302	3,071 Added 9.1%	36,814 $5.64 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $645,646 - $801,065	-4,892 Reduced 12.66%	33,743 $5.47 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $16,066 - $18,237	151 Added 0.39%	38,635 $4.17 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $23,987 - $26,723	228 Added 0.6%	38,484 $4.34 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $488,891 - $538,210	-4,779 Reduced 11.1%	38,256 $4.14 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $47,811 - $64,549	594 Added 1.4%	43,035 $4.61 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $13,573 - $15,931	-158 Reduced 0.37%	42,441 $3.72 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $194,944 - $260,864	2,657 Added 6.65%	42,599 $4.18 Million
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $2,838 - $4,302	44 Added 0.11%	39,942 $3.04 Million
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $79,270 - $99,184	1,099 Added 2.83%	39,898 $3.53 Million
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $507,429 - $610,076	8,057 Added 26.21%	38,799 $2.94 Million
Q2 2019 Aug 02, 2019	SELL	$65.7 - $83.98 $128,377 - $164,096	-1,954 Reduced 5.98%	30,742 $2.24 Million
Q1 2019 May 06, 2019	SELL	$77.14 - $90.79 $30,161 - $35,498	-391 Reduced 1.18%	32,696 $2.64 Million
Q4 2018 Feb 08, 2019	SELL	$77.85 - $96.01 $780,368 - $962,404	-10,024 Reduced 23.25%	33,087 $3.05 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $11,113 - $12,355	-125 Reduced 0.29%	43,111 $4.08 Million
Q2 2018 Dec 21, 2018	BUY	$89.78 - $106.23 $3.02 Million - $3.57 Million	33,614 Added 349.35%	43,236 $4.01 Million
Q2 2018 Aug 09, 2018	SELL	$89.78 - $106.23 $3.67 Million - $4.34 Million	-40,875 Reduced 80.95%	9,622 $891,000
Q1 2018 Dec 21, 2018	BUY	$92.01 - $123.21 $4.05 Million - $5.42 Million	44,009 Added 678.31%	50,497 $4.78 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $278,054 - $372,340	-3,022 Reduced 31.78%	6,488 $614,000
Q4 2017 Feb 02, 2018	BUY	$89.56 - $98.21 $18,538 - $20,329	207 Added 2.23%	9,510 $920,000
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $227,012 - $289,965	-3,250 Reduced 25.89%	9,303 $827,000
Q2 2017 Aug 14, 2017	BUY	N/A	12,553	12,553 $910,000

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cpwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cpwm, LLC with notifications on news.

Account